References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Bristowetal(2000)Evidenceforaccelerateddesensitisationof5-HT2Creceptorsfollowingcombinedtreatmentwithfluoxetineandthe5-HT1Areceptorantagonist,WAY100,635,intherat.Neuropharmacology391222PMID:10760364
Bromidgeetal(1998)Novelandselective5-HT2C/2Breceptorantagonistsaspotentialanxiolyticagents:synthesis,quantitativestructure-activityrelationships,andmolecularmodelingofsubstituted1-(3-pyridylcarbamoyl)indolines.J.Med.Chem.411598PMID:9572885
Hutsonetal(2000)Activationofmesolimbicdopaminefunctionbyphencyclidineisenhancedby5-HT2C/2Breceptorantagonists:neuRochemicalandbehaviouralstudies.Neuropharmacology392318PMID:10974315
Keywords:SB221284,supplier,Potent,selective,5-HT2C,antagonists,SEROtonin,Receptors,5-HT2B,SB221284,5-HT2C,Receptors,5-HT2B,Receptors,5-HT2C,Receptors,TocrisBioscience